EMA Validates Review Of Astellas' PADCEV And KEYTRUDA Combination In Bladder Cancer

Astellas Pharma Inc. (ALPMY, 4503.T) announced that the European Medicines Agency (EMA) has validated for review a Type II variation application for PADCEV (enfortumab vedotin).

Niche Ranker: Marketing 1on1 Announces the Addition of Local Citations to Its Backlink Service Offerings

Marketing 1on1, an SEO and link-building company operating since 2012, announced today that it has officially added local citations to its ...

TOP Ships Inc.: TOP Ships Announces Letter of Intent for Acquisition of Real Estate Assets in Dubai

TOP Ships Inc. (the "Company" or "TOP Ships") (NYSE American:TOPS), an international owner and operator of modern, fuel-efficient "ECO" tanker vessels ...

Hagens Berman Sobol Shapiro LLP: PRMB Lawsuit: Primo Brands Investors Must Act by Jan. 12 Deadline over Botched Merger, CEO Exit

Hagens Berman Urges Investors to Contact Firm Following Revelations of Integration Failure and 36% Stock Crash SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ -- Investor ...

Pharma Corp Rx Inc.: Pharmacorp Rx Inc. Reports Q3 2025 Financial Results

PHARMACORP RX INC. ("PharmaCorp" or the "Corporation") (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ownership ...

Laser Photonics Corp.: Laser Photonics Received NASDAQ Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

ORLANDO, FL / ACCESS Newswire / November 28, 2025 / Laser Photonics Corporation (LPC) (NASDAQ:LASE), a leading global industrial developer of CleanTech Laser Systems for laser cleaning and other appli ...

New Earth Resources Corp.: New Earth Resources Issues Shares under Option Agreement for Red Wine Rare Earth Project in Labrador

NEW EARTH RESOURCES CORP. (CSE: EATH) ("New Earth" or the "Company") is pleased to announce that it has issued 1,250,000 Class A common ...

Pharma Corp Rx Inc.: PharmaCorp Announces Executive Transition and New Director of Business Development

PHARMACORP RX INC. ("PharmaCorp" or the "Corporation") (TSXV: PCRX) today announced an executive transition in which Paul Dale has been appointed ...

Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program

Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies ...

Silver X Mining Corp. Sustains Momentum Through 3Q25 with a Strong Performance in September

Results of the new PEA were strong, with an after-tax NPV of $440M (5% discount rate), LOM cash costs of $11.8/oz AgEq, and AISC of $15.8/oz AgEq, demonstrating the potential to transform Silver X ...

Maris-Tech Ltd. Secures $2 Million Financing to Strengthen its Capital Structure and Support Commercial and U.S. Market Initiatives

Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) ("Maris-Tech" or the "Company"), a global leader in video and artificial intelligence ("AI")- based edge computing ...

Atlantic Petroleum P/F: Atlantic Petroleum - Condensed Consolidated Interim Report - 3rd Quarter 2025

P/F Atlantic Petroleum (NASDAQ Copenhagen: ATLA DKK) today posts its 3rd quarter results for 2025. This announcement should be read in conjunction ...